Sofosbuvir/ velpatasvir

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Hepatitis C, chronic

Manufacturer:

Gilead Sciences Canada, Inc.

Call for patient/clinician input open:

March 23, 2016

Brand Name:

Epclusa

Project Line:

Reimbursement Review

Project Number:

SR0486-000

Call for patient/clinician input closed:

May 12, 2016

NOC Status at Filing:

Pre NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Hepatitis C, chronic

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

October 26, 2016

Last Updated : March 23, 2016